PHIO$0.9032.61%0.023
After Hours: 0.84-0.06 -6.98%
Phio Pharmaceuticals Corp (PHIO)
Date: 2026-11-03 16:00O: 0.8700H: 0.9197L: 0.8700C: 0.9030Vol: 33.01k
Phio Pharmaceuticals Corp stock is traded at $0.903, with a volume of 33,013. It is up +2.61% in the last 24 hours and down -8.33% over the past month. Phio Pharmaceuticals Corp is a clinical-stage biopharmaceutical company whose proprietary INTASYL small-interfering RNA gene silencing technology is designed to make immune cells more effective in killing tumor cells. Its pipeline programs are PH-762 and PH-894. The group is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems. It is committed to discovering and developing cancer treatments for patients by creating new pathways toward a cancer-free future. The Company operates with a single operating segment, the Clinical segment, and all assets are located in the United States.
Previous Close:
$0.88
Open:
$0.87
24h Volume:
33,013
Relative Volume:
0.71
Market Cap:
$10.49M
Revenue:
$153.00K
Net Income/Loss:
-$10.93M
P/E Ratio:
-
EPS:
-$1.44
Net Cash Flow:
-$10.72M
1W Performance:
+1.32%
1M Performance:
-8.33%
6M Performance:
-20.79%
1Y Performance:
-51.45%
1-Day Range:
$0.87$0.9197
1-Week Range:
$0.85$0.9197
52-Week Range:
$0.8127$4.19
Phio Pharmaceuticals Corp Stock (PHIO) Company Profile
Name
Phio Pharmaceuticals CorpSector
HealthcareIndustry
BiotechnologyPhone
(508) 767-3861Address
411 SWEDELAND ROAD, KING OF PRUSSIA, MA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS
Phio Pharmaceuticals Corp Stock (PHIO) Upgrades & Downgrades
Phio Pharmaceuticals Corp Stock (PHIO) Financials Data
Phio Pharmaceuticals Corp Stock (PHIO) Insider Trading
- Plott Ronald ToddSep 29 '26Director
- Transaction
- Buy
- Cost
- $1.04
- #Shares
- 5,000
- Value ($)
- 5,200
- #Shares Total
- 42,000
- Plott Ronald ToddSep 28 '26Director
- Transaction
- Buy
- Cost
- $1.03
- #Shares
- 5,000
- Value ($)
- 5,150
- #Shares Total
- 37,000
- BRADFORD PATRICIA ASep 24 '26Director
- Transaction
- Buy
- Cost
- $1.01
- #Shares
- 6,500
- Value ($)
- 6,583
- #Shares Total
- 64,151
- Bitterman Robert JSep 22 '26Chairman, Pres. & CEO
- Transaction
- Buy
- Cost
- $1.03
- #Shares
- 2,000
- Value ($)
- 2,058
- #Shares Total
- 364,871
- BRADFORD PATRICIA ASep 15 '26Director
- Transaction
- Buy
- Cost
- $1.03
- #Shares
- 12,000
- Value ($)
- 12,360
- #Shares Total
- 57,651
- Plott Ronald ToddAug 19 '26Director
- Transaction
- Buy
- Cost
- $1.14
- #Shares
- 15,000
- Value ($)
- 17,100
- #Shares Total
- 15,000
- Bitterman Robert JAug 18 '26Chairman, Pres. & CEO
- Transaction
- Buy
- Cost
- $1.06
- #Shares
- 10,000
- Value ($)
- 10,600
- #Shares Total
- 431,421
- Bitterman Robert JJun 26 '26Chairman, Pres. & CEO
- Transaction
- Buy
- Cost
- $0.99
- #Shares
- 10,000
- Value ($)
- 9,900
- #Shares Total
- 421,421
- Bitterman Robert JDec 31 '25Chairman, Pres. & CEO
- Transaction
- Buy
- Cost
- $1.03
- #Shares
- 5,000
- Value ($)
- 5,150
- #Shares Total
- 291,421
- Bitterman Robert JDec 23 '25Chairman, Pres. & CEO
- Transaction
- Buy
- Cost
- $1.02
- #Shares
- 5,000
- Value ($)
- 5,100
- #Shares Total
- 286,421
